Feline PIVKA-Ⅱ antibody and antigen (recombinant protein)

Diagnostic anti-Feline PIVKA-Ⅱ antibodies pairs and antigen for animal health (animal Cat/Feline hepatocellular carcinoma) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Companion Animal disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-FEL-PIVKA-Ⅱ-Ag01Feline PIVKA-Ⅱ$3090.00
GMP-FEL-PIVKA-Ⅱ-Ab01Anti-Feline PIVKA-Ⅱ mouse monoclonal antibody (mAb)$3090.00
GMP-FEL-PIVKA-Ⅱ-Ab02Anti-Feline PIVKA-Ⅱ mouse monoclonal antibody (mAb)$3090.00
GMP-FEL-PIVKA-Ⅱ-Ab03Anti-Feline PIVKA-Ⅱ human monoclonal antibody (mAb)$3090.00
GMP-FEL-PIVKA-Ⅱ-Ab04Anti-Feline PIVKA-Ⅱ human monoclonal antibody (mAb)$3090.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. GMP-FEL-PIVKA-Ⅱ-Ag01
Product NameFeline PIVKA-Ⅱ
Target/BiomarkerFeline PIVKA-Ⅱ
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Feline PIVKA-Ⅱ antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PIVKA-Ⅱ level test of animal Cat/Feline with hepatocellular carcinoma.
TagHis
Reconized/Reactive SpecicsFeline PIVKA-Ⅱ
Product descriptionRecombinant Feline PIVKA-Ⅱ protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-FEL-PIVKA-Ⅱ-Ab01,GMP-FEL-PIVKA-Ⅱ-Ab02
Target/BiomarkerFeline PIVKA-Ⅱ
Product NameAnti-Feline PIVKA-Ⅱ mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Feline PIVKA-Ⅱ antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Feline PIVKA-Ⅱ antibodies in Feline PIVKA-Ⅱ level test of animal Cat/Feline with hepatocellular carcinoma.
Product descriptionAnti-Feline PIVKA-Ⅱ mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Feline PIVKA-Ⅱ antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-FEL-PIVKA-Ⅱ-Ab03,GMP-FEL-PIVKA-Ⅱ-Ab04
Target/BiomarkerFeline PIVKA-Ⅱ
Product NameAnti-Feline PIVKA-Ⅱ human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Feline PIVKA-Ⅱ antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Feline PIVKA-Ⅱ antibodies in Feline PIVKA-Ⅱ level test of animal Cat/Feline with hepatocellular carcinoma.
Product descriptionAnti-Feline PIVKA-Ⅱ mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Feline PIVKA-Ⅱ, an intriguing biomarker, takes center stage in the realm of feline health. Exclusive to cats, the significance of this biomarker lies in its role as an indicator of coagulation abnormalities and Vitamin K-dependent clotting factors. Feline PIVKA-Ⅱ serves as a marker that mirrors the intricate interplay between hemostasis, liver function, and the synthesis of clotting factors.

    The presence of Feline PIVKA-Ⅱ is closely tied to the activation of coagulation factors, particularly those reliant on Vitamin K. In instances where Vitamin K metabolism is compromised, the levels of Feline PIVKA-Ⅱ may elevate, reflecting the body's attempt to maintain normal hemostasis despite the impaired clotting factors. Furthermore, variations in Feline PIVKA-Ⅱ levels can signal potential liver dysfunction, as the liver plays a central role in the synthesis of both clotting factors and Vitamin K.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.